Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

Gerber has grown skeptical of Musk's other ventures in recent years, and has said previously that his side projects are ...

Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...

For some, Black Friday kicks off the holiday shopping season, a period of time that Apple (NASDAQ:AAPL) is heavily dependent ...

Wedbush’s Daniel Ives also bumped his price target to $75 from $57, and maintained an “outperform” rating, anticipating that the AI-driven enterprise phase, starting in 2025 with large language models ...

News of an investigation by the Federal Trade Commission into Microsoft (NASDAQ:MSFT) is "not a worry" with Chairwoman Lina ...

We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

Snowflake (SNOW) and Elastic (ESTC) were in focus on Monday as Wedbush Securities upgraded the software companies. Read for ...

Gary Black of The Future Fund LLC confirmed that Tesla's Cybercab won't launch until 2026, dismissing early rollout rumors, ...

Power needs for artificial intelligence and cloud computing are expanding so rapidly that some data center campuses may use ...